Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
Stingl
G
G
University of Vienna, Austria.
Brŏcker
E B
EB
Mertelsmann
R
R
Wolff
K
K
Schreiber
S
S
Kămpgen
E
E
Schneeberger
A
A
Dummer
W
W
Brennscheid
U
U
Veelken
H
H
Birnstiel
M L
ML
Zatloukal
K
K
Schmidt
W
W
Maass
G
G
Wagner
E
E
Baschle
M
M
Giese
M
M
Kempe
E R
ER
Weber
H A
HA
Voigt
T
T
D002985:Clinical Protocols; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000235:genetics*; D008545:Melanoma / Q000235:genetics / Q000556:secondary / Q000628:therapy*; D014162:Transfection; D014612:Vaccines / Q000235:genetics*
D007376:Interleukin-2; D014612:Vaccines